Search

Search Constraints

You searched for: Author/Creator Epelbaum, Stéphane

Search Results

1. [O2–05–04]: IN COGNITIVELY NORMAL INDIVIDUALS, THE BEST CONCORDANCE BETWEEN CSF BIOMARKERS AND PET AMYLOID IS OBSERVED WITH THE COMBINATION OF B‐AMYLOID1–42 AND PHOSPHORYLATED TAU. (1st July 2017)

3. [P1–028]: DIAGNOSTIC ACCURACY OF CSF NEUROFILAMENT LIGHT CHAIN PROTEIN IN THE UNBIASED BIOMARKER‐GUIDED CLASSIFICATION SYSTEM FOR ALZHEIMER's DISEASE. (1st July 2017)

4. [P1–281]: DIAGNOSTIC PERFORMANCE USING CSF YKL‐40 IN ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA. (1st July 2017)

5. [P1–282]: DIAGNOSTIC ACCURACY OF CSF Aβ1–42, P‐TAU, T‐TAU, NEUROFILAMENT LIGHT CHAIN, NEUROGRANIN, YKL‐40 COMBINED BIOMARKERS IN A MULTICENTER COHORT OF COGNITIVELY IMPAIRED PATIENTS. (1st July 2017)

6. [P1–287]: DIAGNOSTIC ACCURACY OF CSF NEUROFILAMENT LIGHT CHAIN PROTEIN IN THE UNBIASED BIOMARKER‐GUIDED CLASSIFICATION SYSTEM FOR ALZHEIMER's DISEASE. (1st July 2017)

7. [P1–388]: DIFFERENT STRUCTURAL CONNECTIVITY PATTERNS IN MILD COGNITIVE IMPAIRMENT STRATIFIED BY AMYLOID AND NEURODEGENERATION BIOMARKERS. (1st July 2017)

8. [P2–260]: TWO‐LEVEL DIAGNOSTIC CLASSIFICATION USING CEREBROSPINAL FLUID NEUROGRANIN IN ALZHEIMER'S DISEASE. (1st July 2017)

9. [P2–379]: ACCURACY OF MRI CLASSIFICATION ALGORITHMS IN A TERTIARY MEMORY CENTER CLINICAL ROUTINE COHORT. (1st July 2017)

10. [P4–184]: LOW COGNITIVE AWARENESS, BUT NOT COMPLAINT, IS A GOOD MARKER OF PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2017)